13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q4 2016. See the latest, Q2 2026 →
Reported value
$748.25B
−0.3% on the quarter before
Positions
2,645
183 new · 184 sold out
Top 10
15.5%
of the value
Est. gain
+$12.52B
on stocks held all quarter
Est. return
+1.8%
on those stocks since Q3 2016
Positions as of Dec 31, 2016, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 25% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2016. Striped tiles are options.
Largest buys
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Bank Amer Corp~$1.46BAdded · 0.5% → 0.9%+66,004,403 shares
- Jpmorgan Chase & Co~$1.36BAdded · 0.7% → 1.1%+15,715,835 shares
- Wells Fargo & Co New~$1.15BAdded · 0.7% → 1.0%+20,925,265 shares
- Microsoft~$1.09BAdded · 1.2% → 1.5%+17,606,133 shares
- Goldman Sachs~$891.3MAdded · 0.1% → 0.3%+3,722,471 shares
- Ishares Inc~$774.4MNew · 0.0% → 0.1%+15,849,460 shares
- Coty Inc~$684.3MAdded · 0.1% → 0.2%+37,372,931 shares
- Envision Healthcare Corp~$650.7MNew · 0.0% → 0.1%+10,280,731 shares
- Lyondellbasell Industries N~$607.0MAdded · 0.2% → 0.3%+7,075,742 shares
- Amgen Inc~$605.9MAdded · 0.8% → 0.8%+4,144,154 shares
Largest sells
Since Q3 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Medtronic Plc~$1.18BCut · 0.9% → 0.6%−16,513,403 shares
- Roper Technologies Inc~$1.12BCut · 0.2% → 0.0%−6,094,674 shares
- Meta~$1.07BCut · 2.4% → 2.0%−9,326,116 shares
- Nvidia~$1.07BCut · 0.7% → 1.0%−10,023,772 shares
- Visa Inc.~$1.01BCut · 1.1% → 0.9%−13,004,564 shares
- Nxp Semiconductors N V~$991.5MCut · 0.3% → 0.2%−10,116,827 shares
- Cvs Health Corp~$931.3MCut · 0.5% → 0.3%−11,802,431 shares
- Ishares~$815.2MSold out · 0.1% → 0.0%−65,010,648 shares
- Alphabet~$783.1MCut · 2.0% → 1.8%−988,153 shares
- Alphabet~$768.5MCut · 1.6% → 1.5%−995,706 shares
Holdings
As of Dec 31, 2016. Changes are in shares against Sep 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −2.4% · price +2.5% | 2.4% | $18.30B | +$437.6M | ||||||||
| MetaCL A · shares −6.6% · price −10.3% | 2.0% | $15.30B | −$1.76B | ||||||||
| AmazonCOM · shares −2.7% · price −10.4% | 1.9% | $14.50B | −$1.69B | ||||||||
| AlphabetCAP STK CL A · shares −5.4% · price −1.4% | 1.8% | $13.74B | −$201.3M | ||||||||
| MicrosoftCOM · shares +11% · price +7.9% | 1.5% | $11.02B | +$725.2M | ||||||||
| AlphabetCAP STK CL C · shares −6.6% · price −0.7% | 1.5% | $10.95B | −$77.6M | ||||||||
| Unitedhealth Group IncCOM · shares +0.9% · price +14.3% | 1.2% | $8.93B | +$1.11B | ||||||||
| Jpmorgan Chase & CoCOM · shares +19% · price +29.6% | 1.1% | $8.33B | +$1.59B | ||||||||
| Wells Fargo & Co NewCOM · shares +18% · price +24.5% | 1.0% | $7.63B | +$1.27B | ||||||||
| NvidiaCOM · shares −13% · price +55.8% | 0.99% | $7.44B | +$2.66B | ||||||||
| Berkshire Hathaway Inc DelCL A · shares 0% · price +12.9% | 0.95% | $7.12B | +$813.8M | ||||||||
| Visa Inc.COM CL A · shares −13% · price −5.7% | 0.95% | $7.10B | −$425.7M | ||||||||
| Bank Amer CorpCOM · shares +26% · price +41.2% | 0.94% | $7.05B | +$1.63B | ||||||||
| Amgen IncCOM · shares +11% · price −12.3% | 0.80% | $5.96B | −$754.9M | ||||||||
| SalesforceCOM · shares −7.1% · price −4.0% | 0.77% | $5.75B | −$241.3M | ||||||||
| Citigroup IncCOM NEW · shares −0.9% · price +25.8% | 0.71% | $5.32B | +$1.09B | ||||||||
| Chevron Corp NewCOM · shares −9.4% · price +14.4% | 0.66% | $4.93B | +$618.6M | ||||||||
| TeslaCOM · shares +13% · price +4.7% | 0.63% | $4.71B | +$188.1M | ||||||||
| Home Depot IncCOM · shares −9.3% · price +4.2% | 0.61% | $4.55B | +$183.1M | ||||||||
| QualcommCOM · shares +3.7% · price −4.8% | 0.59% | $4.45B | −$217.2M | ||||||||
| MastercardCL A · shares −7.5% · price +1.5% | 0.58% | $4.38B | +$62.7M | ||||||||
| Medtronic PlcSHS · shares −22% · price −17.6% | 0.56% | $4.19B | −$892.9M | ||||||||
| General Electric CoCOM · shares +0.7% · price +6.7% | 0.55% | $4.13B | +$257.1M | ||||||||
| Activision Blizzard IncCOM · shares +0.2% · price −18.5% | 0.54% | $4.03B | −$910.8M | ||||||||
| Starbucks CorpCOM · shares −13% · price +2.5% | 0.53% | $3.99B | +$99.2M | ||||||||
| Total · 2,645 positions | 100% | $748.25B | +$12.52B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2016 to Q4 2016: 2,400 stocks held throughout, up $12.52B (+1.8%).
- Nvidia+$2.66B+56%
- Bank Amer Corp+$1.63B+41%
- Jpmorgan Chase & Co+$1.59B+30%
- Wells Fargo & Co New+$1.27B+24%
- Unitedhealth Group Inc+$1.11B+14%
- Amgen Inc−$754.9M−12%
- Medtronic Plc−$892.9M−18%
- Activision Blizzard Inc−$910.8M−18%
- Amazon−$1.69B−10%
- Meta−$1.76B−10%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 5 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |
